Related Experiment Video
Updated: May 18, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Involvement of dendritic cells frequency and function in outcomes of interferon-alpha therapy for chronic hepatitis
Yan-Li Zhang1, Feng Liu, Ming-Hui Li
1Liver Center of Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Insights
Interferon-alpha therapy for chronic hepatitis B (CHB) increases plasmacytoid dendritic cell (pDC) frequency and function in responders. Myeloid dendritic cell (mDC) frequency and function decrease in non-responders, indicating their role in treatment outcomes.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Chronic hepatitis B (CHB) is a significant global health concern.
- Interferon-alpha (IFN-alpha) is a treatment option for CHB.
- Dendritic cells (DCs), including myeloid (mDC) and plasmacytoid (pDC) subsets, play crucial roles in immune responses.
Purpose of the Study:
- To investigate the changes in mDC and pDC frequencies and functions during IFN-alpha therapy in CHB patients.
- To correlate these DC changes with virological and biochemical treatment responses.
Main Methods:
- Flow cytometry was used to analyze peripheral blood mDC and pDC frequencies and CD86 expression in 30 HBeAg-positive CHB patients before and after 12 weeks of IFN-alpha therapy.
- Patients were stratified into groups based on alanine aminotransferase (ALT) normalization and virological response.
Main Results:
- In patients with normalized ALT, pDC frequency increased significantly post-therapy (P=0.023).
- In non-normalized ALT patients, mDC frequency and CD86 expression decreased significantly (P=0.025, P=0.036).
- In virological responders, pDC CD86 expression increased (P=0.002), while in non-responders, mDC frequency and CD86 expression decreased significantly (P=0.006, P=0.049).
Conclusions:
- Increased pDC frequency and function correlate with biochemical and virological response to IFN-alpha therapy in CHB.
- Decreased mDC frequency and function are associated with non-response to IFN-alpha therapy in CHB.
- These findings highlight the differential roles of mDC and pDC subsets in predicting IFN-alpha treatment outcomes for CHB.
Objective:
To elucidate the change in frequencies and functions of myeloid dendritic cell (mDC) and plasmacytoid dendritic cell (pDC) before and after interferon-alpha therapy for chronic hepatitis B (CHB) patients, and its correlation with virological and biochemical data.
Methods:
Thirty patients with HBeAg-positive CHB who underwent IFN-alpha therapy were examined. Frequencies and expression of CD86 of mDC and pDC of peripheral blood were measured at baseline and treatment week (TW) 12 by flow cytometry. According to biochemical and virological parameters, the 30 patients were divided into ALT normalized group, ALT non-normalized group and virological responder group, virological non-responder group respectively. Statistical analysis of DC changes among different groups at baseline and TW12 was proceeded.
Results:
(1) In the ALT normalized group, the pDC frequency at TW12 (0.25 +/- 0.14%) was higher than that at baseline (0.18 +/- 0.09%) (P = 0.023); in the ALT non-normalized group, the mDC frequency (0.58 +/- 0.34%) and its surface CD86 expression (61.80 +/- 22.52%) decreased significantly as compared with baseline (0.88 +/- 0.51%, 79.92 +/- 25.94%, respectively), (P = 0.025, P = 0.036, respectively). (2) In the virological responder group, the CD86 expression on pDC at TW12 (46.86 +/- 12.22%) was higher than that at baseline (29.42 +/- 15.16%) (P = 0.002); in the virological non-responder group, the mDC frequency (0.51 +/- 0.22%) and its surface CD86 expression (59.63 +/- 22.94% ) decreased significantly as compared with baseline (0.94 +/- 0.58%, 80.11 +/- 29.34%, respectively), (P = 0.006; P = 0.049, respectively).
Conclusion:
In IFN-alpha therapy for CHB patients, the increments of pDC frequency and function were related to biochemical and viral response, and decreases of mDC frequency and function were related to non-biochemical and non-viral response.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
08:11Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...